Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · GBL

Is GBL legal in Germany?

Also known as: blue nitro

Confirmed against a primary sourceVerified October 8, 2026
Legal status
GBL is placed by the Neue-psychoaktive-Stoffe-Gesetz through a named line in Anlage 2, which is a different list from the Anlage 1 substance groups and it enters the Act by a different door. The printed row reads „γ-Butyrolacton | Stoff: Reinstoff; Zubereitung: jede Zubereitung mit einem Gehalt von mehr als 20 Prozent... | Gamma-Butyrolacton, GBL... | Oxolan-2-on | 202-509-5“, so the substance column is qualified by a threshold on its face: the pure substance, and preparations above twenty per cent. An Anlage 2 line is reached through § 2 Nr. 1 Buchst. b, which is the definition limb for listed individual substances, as against Buchst. a for the Anlage 1 groups. This is not a narcotics result: no BtMG line is placed against this substance, and the two statutes are not read together here.
Consequences if caught
Capital exposure: none. Germany has no death penalty. The listing and the penalty are separate questions on this row and the separation has to be kept, because an Anlage 2 substance does not enter the prohibition unconditionally. Under § 3 Abs. 1 Nr. 1 a listed substance of this kind is caught only where it carries the properties set out in the third column of Anlage 2, and the dossier's transcription of this row does not reproduce that cell, so this cell does not state what it holds. Two further prohibitions in § 3 Abs. 1 attach to Anlage 2 substances specifically, over distance selling and vending machines and over supply to persons under eighteen. The offence provision is narrower than all of that: § 4 Abs. 1 punishes trading, placing on the market and administering to another, and manufacture or import for the purpose of placing on the market, so a prohibition here does not by itself produce a penalty. The dossier carries across the aggravated figure at § 4 Abs. 3, one to ten years, which belongs to the offence provision rather than to the listing, and it is not adopted as the consequence of this placement. Sections read at gesetze-im-internet.de on 21 September 2026.
If prescribed or medical
No prescribing route arises, and the reason is that the substance is not a medicine question at all: it holds no BtMG Anlage placement, so no tier of the narcotics schedules applies, and the statute that does place it works by prohibition with exemptions for recognised commercial, industrial and scientific uses. The dossier records no German prescription or traveller rule for this row, so the cell defers on the border question rather than describing one.
Documentation
The number to check is the concentration, because the listed properties in the dossier's transcription are the pure substance and preparations above twenty per cent, which means a product's own composition decides whether the row reaches it. An industrial use has to answer the statute's own exemption rather than a licence. The row was read on 20 September 2026.
Primary sources
  • Germany, Neue-psychoaktive-Stoffe-Gesetz, Anlage 2, the table row „γ-Butyrolacton“ with the substance and preparation properties recorded by the dossier, read at https://www.gesetze-im-internet.de/npsg/anlage_2.html on 20 September 2026
  • the Anlage 2 entry route at § 2 Nr. 1 Buchst. b, the prohibitions in § 3 Abs. 1 and the offence in § 4, read at https://www.gesetze-im-internet.de/npsg/ on 21 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Germany

Same substance, other countries